Table Name: `per_visit`
Description: Patient level clinical demographic information, obtained from the clinic. If column description is missing, avoid using it unless explicitly asked to.
column_number | name | description
1	PUBLIC_ID	Index column. Patient public identifier. Last 4 digits are unique. e.g. MMRF_1234
2	SPECTRUM_SEQ	Ignore this column
3	VISIT	A unique number assigned to the visit. e.g. 1 means first visit at which diagnosis was made.
4	VJ_INTERVAL	Record Interval
5	VISITDY Day of Visit
6	AT_DEFINITEDEVEL	
7	AT_WASANASSESSME	Was an assessment of treatment response performed since the last study visit?
8	AT_RESPONSEASSES	
9	AT_TREATMENTRESP	Treatment Response
13	AT_INCREASEOF25F	
14	AT_SERUMMCOMPONE	
15	AT_URINEMCOMPONE	
16	AT_ONLYINPATIENT	
17	AT_ONLYINPATIENT2	
18	AT_DEVELOPMENTOF	
19	BA_WASABONEASSES	Was a bone assessment done since the last study visit?
20	BA_DAYOFASSESSM	Date of assessment
21	BA_TYPEOFBONEASS	Type of bone assessment
22	BA_SPECIFY	Other bone assessment, specify
23	BA_IMAGEINTERPRE	Image Interpretation
24	BA_LYTICLESIONS	Lytic Lesions
25	BA_OFLYTICLESION	# of Lytic Lesions
26	BA_OSTEOPENIAOST	Osteopenia / Osteoporosis
27	BA_PATHOLOGICFRA	Pathologic fracture
28	BA_MULTIPLEDISSE	Multiple disseminated lesions
29	BA_SKULL	Yes/No bone lesion assessment for Skull
30	BA_SPINE	Yes/No bone lesion assessment for Spine
31	BA_CERVICAL	Yes/No bone lesion assessment for Cervical
32	BA_THORACIC	Yes/No bone lesion assessment for Thoracic
33	BA_LUMBAR	Yes/No bone lesion assessment for Lumbar
34	BA_SACRAL	Yes/No bone lesion assessment for Sacral
35	BA_PELVIS	Yes/No bone lesion assessment for Pelvis
36	BA_RIGHT	Yes/No bone lesion assessment for Right region 1
37	BA_LEFT	Yes/No bone lesion assessment for Left region 2
38	BA_FEMUR	Yes/No bone lesion assessment for Femur
39	BA_RIGHT2	Yes/No bone lesion assessment for Right region 2
40	BA_LEFT2	Yes/No bone lesion assessment for Left region 2
41	BA_HUMERUS	Yes/No bone lesion assessment for Humerus
42	BA_RIGHT3	Yes/No bone lesion assessment for Right region 3
43	BA_LEFT3	Yes/No bone lesion assessment for Left region 3
44	BA_RIBS	Yes/No bone lesion assessment for Ribs
45	BA_RIGHT4	Yes/No bone lesion assessment for Right region 4
46	BA_NUMBERAFFECTE	Number of ribs affected (right side)
47	BA_LEFT4	Yes/No bone lesion assessment for Left region 4
48	BA_NUMBERAFFECTE2	Number of ribs affected (leftt side)
49	BA_OTHER	Yes/No bone lesion assessment for Other
50	BB_SPECIFY	Specify for BA_OTHER
51	BB_REASONFORPROC	Reason for procedure
52	BB_CELLULARITY2	
53	BB_PERCENTOFPLAS	Percent of plasma cells
54	BB_WASABONEMARRO	Was a bone marrow biopsy performed since the last study visit?
55	BB_DAYOFCOLLECT	Date of collection
56	BB_WASBIOPSYSPEC	Was biopsy specimen adequate for cellularity?
57	BB_IFNOPLEASESPE	If biopsy specimen not adequate for cellularity, specify
58	BB_CELLULARITY	
59	BONE_WASABONEMARRO	Was a bone marrow aspirate performed since the last study visit?
60	BONE_DAYOFCOLLECT	BMA date of collection
61	BONE_WASBONEMARROW	Was bone marrow sample sent to the Spectrum Health?
62	BONE_VOLUMEOFBMASP	
63	BONE_PLASMAUNK	Volume of BMA unknown
64	BONE_BMAVOLUMESENT	
65	BONE_BMAUNK	Volume of bma sent to CoMMpass Central Lab unknown
66	BONE_WASPERIPHERAL	Was peripheral blood sent to the Spectrum Health?
67	BONE_DAYOFCOLLECT2	
68	BONE_PC6	BMA: (%PC positive for CD138 by IHC) - reported as %PC
69	BONE_PERCENTOFPLAS	BMA: (%PC positive for CD138 by IHC) - %PC
70	BONE_REASONFORPROC	
71	BONE_SPECIFY2	Other reason for procedure, specify
72	BONE_PERCENTOFPLAS3	
74	BONE_REPORTEDASPER	BMA: Reported as %PC by cytomorphology (smear)
75	BONE_RANGEOFPLASMA2	BMA: (%PC positive for CD138 by IHC) - reported as %PC range
76	BONE_RANGELOW	BMA: (%PC positive for CD138 by IHC) -  %PC low end of range
77	BONE_RANGEHIGH	BMA: (%PC positive for CD138 by IHC) - %PC high end of range
78	BONE_RANGEUNK	BMA: (%PC positive for CD138 by IHC) - not done/unknown
79	BONE_BCYTOMORPHOLO	
80	BONE_PC7	BMA: (%PC by cytomorphology (smear)) - reported as %PC
81	BONE_PC2	BMA: (%PC by cytomorphology (smear)) - %PC
82	BONE_RANGEOFPLASMA3	BMA: (%PC by cytomorphology (smear)) - reported as %PC range
83	BONE_RANGELOW2	BMA: (%PC by cytomorphology (smear)) -  %PC low end of range
84	BONE_RANGEHIGH2	BMA: (%PC by cytomorphology (smear)) - %PC high end of range
85	BONE_FCAUNK	BMA: (%PC by cytomorphology (smear)) - not done/unknown
86	BONE_AFLOWCYTOMETR	BMA: Reported as %cells positive by flow cytometry(FLOW)
87	BONE_PC8	BMA: (%cells positive by FLOW) - reported as %PC
88	BONE_REPORTEDBYCYT	BMA: (%cells positive by FLOW) - %PC
89	BONE_RANGEOFPLASMA4	BMA: (%cells positive by FLOW) - reported as %PC range
90	BONE_RANGELOW3	BMA: (%cells positive by FLOW) -  %PC low end of range
91	BONE_RANGEHIGH3	BMA: (%cells positive by FLOW) - %PC high end of range
92	BONE_UNKNOWN	BMA: (%cells positive by FLOW) - not done/unknown
93	BONE_PC	
95	BONE_REPORTEDASPER2	PC in clot section or BM biopsy: Reported as %PC positive for CD138 by IHC
96	BONE_PC9	PC in clot section or BM biopsy: (%PC positive for CD138 by IHC) - reported as %PC
97	BONE_PC3	PC in clot section or BM biopsy: (%PC positive for CD138 by IHC) - %PC
98	BONE_RANGEOFPLASMA5	PC in clot section or BM biopsy: (%PC positive for CD138 by IHC) - reported as %PC range
99	BONE_RANGELOW4	PC in clot section or BM biopsy: (%PC positive for CD138 by IHC) -  %PC low end of range
100	BONE_RANGEHIGH4	PC in clot section or BM biopsy: (%PC positive for CD138 by IHC) - %PC high end of range
101	BONE_LOWVALUE	PC in clot section or BM biopsy: (%PC positive for CD138 by IHC) - not done/unknown
102	BONE_REPORTEDASPER3	PC in clot section or BM biopsy: Reported as %PC by cytomorphology (smear)
103	BONE_PC10	PC in clot section or BM biopsy: (%PC by cytomorphology (smear)) - reported as %PC
104	BONE_PC4	PC in clot section or BM biopsy: (%PC by cytomorphology (smear)) - %PC
105	BONE_RANGEOFPLASMA6	PC in clot section or BM biopsy: (%PC by cytomorphology (smear)) - reported as %PC range
106	BONE_RANGELOW5	PC in clot section or BM biopsy: (%PC by cytomorphology (smear)) -  %PC low end of range
107	BONE_RANGEHIGH5	PC in clot section or BM biopsy: (%PC by cytomorphology (smear)) - %PC high end of range
108	BONE_HIGHVALUE	PC in clot section or BM biopsy: (%PC by cytomorphology (smear)) - not done/unknown
109	BONE_RANGEOFPLASMA	PC in clot section or BM biopsy: Reported as %cells positive by flow cytometry(FLOW)
110	BONE_PC11	PC in clot section or BM biopsy: (%cells positive by FLOW) - reported as %PC
111	BONE_PC5	PC in clot section or BM biopsy: (%cells positive by FLOW) - %PC
112	BONE_RANGEOFPLASMA7	PC in clot section or BM biopsy: (%cells positive by FLOW) - reported as %PC range
113	BONE_RANGELOW6	PC in clot section or BM biopsy: (%cells positive by FLOW) -  %PC low end of range
114	BONE_RANGEHIGH6	PC in clot section or BM biopsy: (%cells positive by FLOW) - %PC high end of range
115	BONE_NOTDONEUNKNOW	PC in clot section or BM biopsy: (%cells positive by FLOW) - not done/unknown
116	BONE_DOESTHEPCRESU	Does the %PC result reported above apply to BMA specimen taken at the same time as the specimen submitted to CoMMpass Central Lab
117	BMT_WASABONEMARRO	Was a bone marrow transplant performed?
118	BMT_DAYOFTRANSPL	Date of transplant
119	BMT_AUTOLOGOUS	Autologous
120	BMT_ALLOGENIC	Allogenic
121	BMT_PLEASESPECIFY	Please specify type of Allogenic transplant
122	BMT_SPECIFY	Other type of allogenic transplant, specify
123	BMT_STEMCELLS	Stem cells
124	BMT_BONEMARROW	Bone marrow
125	BMT_NUMBER	Number
126	ECOG_PERFORMANCEST	Performance Status
127	ECOG_WASANECOGASSE	Was an ECOG assessment performed since the last study visit?
128	ECOG_ASSESSMENTDAT	Assessment Date
129	IC_DAYOFINFORME	Date of Informed Consent
130	IC_DAYOFVISIT	Date of visit
131	IC_DAYUNIVERSAL	Date Universal Consent signed
132	IC_DIDTHEPATIENT	Did the patient meet all eligibility requirements for this study?
133	IC_HASTHEPATIENT	The patient has signed the Universal Informed Consent
134	IC_IFYESPLEASEPR	If yes, please provide Date of Informed Consent
135	IC_INVOLVEDFREEL	Involved free light chain level &#8805; 10 mg/dl and an abnormal serum free light chain ratio (<0.26 or >1.65)
136	IC_IPERMITMYSAMP	I permit my Samples and correlating health information to be stored at the MMRF Longitudinal Study Biobank and MMRF Databank, respectively, and used by the MMRF, other organizations and researchers fo
137	IC_IPERMITMYSAMP2	I permit my Samples and correlating health information to be used by the MMRF, other organizations and researchers in the Study and future research to learn about, prevent, or treat any other disorder
138	IC_IPERMITRESEAR	I permit researchers at the facility to contact me in the future for an update on my status, or to discuss potential studies which may be appropriate for me
139	IC_NOMORETHAN30D	No more than 30 days from baseline bone marrow evaluation as per this protocol to initiation of first-line therapy.
140	IC_OTHREASON	Other reason for ineligibility?
141	IC_PARTICIPATEPSS	Has the patient agreed to participate in the Patient Support Services
142	IC_PATIENTHADANO	Patient had another malignancy within the last 5 years (except for basal or squamous cell carcinoma, or in situ cancer of the cervix).
143	IC_PATIENTHASREA	Patient has read, understood and signed informed consent.
144	IC_PATIENTISALRE	Patient is already receiving systemic therapy for MM (a single dose of bisphosphonates and up to 100 mg total dose of dexamethasone or equivalent corticosteroids are permitted prior to registration on
145	IC_PATIENTISATLE	Patient is at least 18 years old
146	IC_PATIENTISENRO	Patient is enrolled in a blinded clinical trial for the first-line treatment of multiple myeloma. Patients may be enrolled in subsequent clinical trials as long as continued access to data and tissue,
147	IC_SERUMMPROTEIN	Serum M protein &#8805; 1g/dl IC_THEPATIENTISA="The patient is a candidate for systemic therapy that includes anIMiD® (e.g., lenalidomide, pomalidomide, thalidomide) and/orproteasome inhibitor (e.g., bortezomib, carfilzomib) as part of theinitia"
148	IC_THEPATIENTISA	The patient is a candidate for systemic therapy that includes an IMiDÂ® (e.g., lenalidomide, pomalidomide, thalidomide) and/or proteasome inhibitor (e.g., bortezomib, carfilzomib) as part of the initia
149	IC_URINEMPROTEIN	Urine M protein &#8805; 200 mg/24 hrs
150	IC_WASTHISPATIEN2	Was this patient previously consented for this study?
151	MMSURG_SPECIFY	Other multiple myeloma surgery, specify
152	MMSURG_NONE	No multiple myeloma surgery
153	MMSURG_VERTEBROPLAST	Vertebroplasty
154	MMSURG_KYPHOPLASTY	Kyphoplasty
155	MMSURG_OTHER	Other multiple myeloma surgery
156	PN_WASANEUROLOGI	Was a neurologic assessment performed since the last study visit?
157	PN_ASSESSMENTDAT	Peripheral neuropathy assessment date
158	PN_PERIPHERALSEN	Peripheral sensory neuropathy present?
159	PN_IFYESINDICATE	If peripheral sensory neuropathy, indicate grade
160	PN_PERIPHERALMOT	Peripheral motor neuropathy present?
161	PN_IFYESINDICATE2	If peripheral motor neuropathy, indicate grade
162	SE_CAUSEOFDEATH	Cause of Death
163	SE_DAYOFDEATH	Date of Death
164	SE_DAYPATIENTCO	
165	SE_DIDPATIENTCOM	Did patient complete the study?
166	SE_LASTKNOWNDAY	Last known date alive
167	SE_PRIMARYREASON	Primary Reason for Discontinuation
168	SE_SPECIFY	Specify
169	SE_SPECIFY2	Specify
170	SUPP_ANTICOAGULATI	Anticoagulation
171	SUPP_NONE	None
172	SUPP_TRANSFUSION	Transfusion
173	SUPP_PACKEDREDBLOO	Packed red blood cells
174	SUPP_PLATELETS	Platelets
175	SUPP_OTHER	Other
176	SUPP_SPECIFY	Other supportive therapy, specify
177	SUPP_RADIOTHERAPY	Radiotherapy
178	SUPP_SPECIFYSITE	Specify site of radiotherapy
179	SUPP_DIALYSIS	Dialysis
180	SUPP_BISPHOSPHONAT	Bisphosphonates or other bone-directed therapy
181	SUPP_WBCGROWTHFACT	WBC growth factors
182	SUPP_ERYTHROPOIESI	Erythropoiesis stimulating agent
183	SUPP_ANTIEMETIC	Antiemetic
184	SUPP_ANALGESICSFOR	Analgesics for bone pain
185	SUPP_OPIOID	Opioid
186	SUPP_OTHER2	Other
187	SUPP_ANTIVIRAL	Antiviral
188	SUPP_MEDICATIONSFO	Medications for neuropathic pain
189	SUPP_MEDICATIONSFO2	Medications for tumor lysis syndrome
190	SS_ISTHEPATIENTR	Is the patient returning for their regular scheduled follow-up?
191	SS_DAYOFVISIT	Date of Visit
192	SS_DOESTHEPATIEN	Does the patient have evidence of symptomatic myeloma related to organ damage, tissue impairments or other symptoms?
193	SS_SPINALCORDCOM	Spinal cord compression
194	SS_BONEPAIN	Bone pain
195	SS_FATIGUE	Fatigue
196	SS_HYPERCALCEMIA	Hypercalcemia (corrected calcium > 11.5 mg/dl)
197	SS_RENALINSUFFIC	Renal insufficiency attributable to myeloma
198	SS_ANEMIAHEMOGLO	Anemia (hemoglobin <10 g/dL)
199	SS_BONELESIONSLY	Bone Lesions - Lytic Lesions
200	SS_BONELESIONSOS	Bone Lesions - Osteoporosis with compression fractures
201	SS_SOFTTISSUEPLA	Soft Tissue Plasmacytoma - Single
202	SS_OFTTISSUEPLAS	Soft Tissue Plasmacytoma - Multiple
203	SS_RECURRENTBACT	Recurrent bacterial infections
204	SS_SYMPTOMATICHY	Symptomatic hyperviscosity
205	SS_AMYLOIDOSIS	Amyloidosis
206	SS_OTHER	Other
207	SS_SPECIFY	Specify
208	ST_PLASMACYTOMAN	Plasmacytoma number
209	ST_INCREASEINNUM	Was there an increase in Number
210	ST_PLASMACYTOMAN2	Plasmacytoma number
211	ST_RESULTOFEXAMI2	Result of examination
212	ST_WASANASSESSME	Was an assessment for soft tissue plasmacytomas performed since the last study visit?
213	ST_ASSESSMENTDAT	Date of soft tissue plasmacytoma assessment
214	ST_WEREANYSOFTTI	Were any soft tissue plasmacytomas present during this exam?
215	ST_NUMBEROFPLASM	Number of plasmacytomas
216	ST_WASTHEREACHAN	Was there a change in Plasmacytomas since last visit
217	ST_INCREASEINSIZE	Was there an increase in Size
218	ST_RESULTOFEXAMI	Result of Examination
219	D_IM_DCL_PATIENT_ID	Public Patient ID
220	D_IM_COLLECTION_DAY	Collection Date
221	D_IM_PROCESSING_DAY	Processing Date
222	D_IM_PATIENTS__MMRF_ELIGIBILITY	MMRF Eligibility Status
223	D_IM_IGH_SITE	IGH Site
224	D_IM_IGL_SITE	IGL Site
225	D_IM_MORPHOLOGY_PERCENT_PC_IN_BM	Morphology %PC in bone marrow
226	D_IM_FLOWCYT_PCT_PC_IN_BM_LOW	Flow cytometer %PC in bone marrow-Low
227	D_IM_FLOWCYT_PCT_PC_IN_BM_HIGH	Flow cytometer %PC in bone marrow-High
228	D_IM_MORPHOLOGY_PERCENT_PC_IN_PB	Morphology %PC in peripheral blood
229	D_IM_FLOWCYT_PCT_PC_IN_PB_LOW	Flow cytometer %PC in peripheral blood-Low
230	D_IM_FLOWCYT_PCT_PC_IN_PB_HIGH	Flow cytometer %PC in peripheral blood-High
231	D_IM_CD38_DETECTED	CD38 Detected
232	D_IM_CD38_PC_PERCENT	CD38 PC%
233	D_IM_CD38_DESCRIPTION	CD38 Description
234	D_IM_CD138_DETECTED	CD138 Detected
235	D_IM_CD138_PC_PERCENT	CD138 PC%
236	D_IM_CD138_DESCRIPTION	CD138 Description
237	D_IM_CD45_PC_TYPICAL_DETECTED	CD45 PC Typical Detected
238	D_IM_CD45_PC_PERCENT	CD45 PC%
239	D_IM_CD45_DESCRIPTION	CD45 Description
240	D_IM_CD56_DETECTED	CD56 Detected
241	D_IM_CD56_PC_PERCENT	CD56 PC%
242	D_IM_CD56_DESCRIPTION	CD56 Description
243	D_IM_CD13_DETECTED	CD13 Detected
244	D_IM_CD13_PC_PERCENT	CD13 PC%
245	D_IM_CD19_DETECTED	CD19 Detected
246	D_IM_CD19_PC_PERCENT	CD19 PC%
247	D_IM_CD20_DETECTED	CD20 Detected
248	D_IM_CD20_PC_PERCENT	CD20 PC%
249	D_IM_CD27_DETECTED	CD27 Detected
250	D_IM_CD27_PC_PERCENT	CD27 PC%
251	D_IM_CD28_DETECTED	CD28 Detected
252	D_IM_CD28_PC_PERCENT	CD28 PC%
253	D_IM_CD33_DETECTED	CD33 Detected
254	D_IM_CD33_PC_PERCENT	CD33 PC%
255	D_IM_CD52_DETECTED	CD52 Detected
256	D_IM_CD52_PC_PERCENT	CD52 PC%
257	D_IM_CD81_DETECTED	CD81 Detected
258	D_IM_CD81_PC_PERCENT	CD81 PC%
259	D_IM_CD117_DETECTED	CD117 Detected
260	D_IM_CD117_PC_PERCENT	CD117 PC%
261	D_IM_CD319_DETECTED	CD319 Detected
262	D_IM_CD319_PC_PERCENT	CD319 PC%
263	D_IM_fgfr3_char	FGFR3 (character)
264	D_IM_FGFR3_PC_PERCENT	FGFR3 PC%
265	D_IM_LIGHT_CHAIN_BY_FLOW	Light Chain by Flow
266	D_IM_FLOWCYT_PCT_ANEUPLOID_POPUL	Flow cytometer %aneuploidy population
267	D_IM_DNA_INDEX	DNA Index
268	D_IM_BRAF_STATUS	BRAF Status
269	D_IM_BRAF_CDNA_VARIANT	BRAF CDNA Variant
270	D_IM_BRAF_PROTEIN_VARIANT	BRAF Protein Variant
271	D_IM_fgfr3_detected	FGFR3 Detected
272	D_IM_visitseq	Sample sequence
273	D_IM_cd38des	CD38 Description(coded)
274	D_IM_cd56des	CD56 Description(coded)
275	D_IM_cd138des	CD138 Description(coded)
276	D_IM_cd45d	CD45 Description(coded)
277	D_IM_igh	IGH Site(coded)
278	D_IM_igl	IGl Site(coded)
279	D_IM_lightc	Light Chain by Flow(coded)
280	D_IM_aneupgp	Aneuploidy group code
281	D_IM_mrgday	Collection or Processing Date
282	D_IM_BONE_REASONFORPROC	Reason for procedure reported on CRF
283	D_IM_BONE_SPECIFY2	Reason for procdure on CRF, specify
284	D_IM_pddt	Correlated disease progression date
285	D_IM_crdt	Correlated Cr/sCR date
286	D_IM_enr	Enrollment population flag
287	D_IM_reason	Derived reason for sample
288	D_IM_crdiff	Days away from closest CR/sCR date
289	D_IM_pddiff	Days away from closest PD date
290	D_IM_det_plasma_cells	Flag for detectable plasma cells (%PC in BM High > 0)
291	D_IM_detectable	Flag for at least one CD marker detected
292	D_IM_kaplam	Light chain either kappa or lambda
293	D_IM_crhit	Flag for an acceptable sample for CR
294	D_IM_pdhit	Flag for an acceptable sample for PD
295	D_IM_hit	Flag for an acceptable sample
296	D_LAB_cbc_abs_neut	Absolute Neutrophil count x10^9/L
297	D_LAB_chem_albumin	Albumin (g/L)
298	D_LAB_chem_bun	Blood Urea Nitrogen (mmol/L)
299	D_LAB_chem_calcium	Calcium (mmol/L)
300	D_LAB_chem_creatinine	Serum Creatinine (umol/L)
301	D_LAB_chem_glucose	Glucose (mmol/L)
302	D_LAB_cbc_hemoglobin	Hemogobin (mmol/L
303	D_LAB_serum_kappa	Serum Kappa (mg/dL)
304	D_LAB_chem_ldh	LDH (ukat/L)
305	D_LAB_serum_m_protein	Serum M Protein (g/dL)
306	D_LAB_cbc_platelet	Platelet count x10^9/L
307	D_LAB_chem_totprot	Total Protein (g/dL)
308	D_LAB_cbc_wbc	White Blood Count  x10^9/L
309	D_LAB_serum_iga	Serum IgA (g/L)
310	D_LAB_serum_igg	Serum IgG (g/L)
311	D_LAB_serum_igm	Serum IgM (g/L)
312	D_LAB_serum_beta2_microglobulin	Beta 2 Microglobulin (mcg/mL)
313	D_LAB_serum_lambda	Serum Lambda (mg/dL)
314	D_LAB_urine_24hr_m_protein	24 hr Urine M Protein (g/24 hr)
315	D_LAB_urine_24hr_total_protein	24 hr Urine Total Protein (g/24 hr)
316	D_LAB_serum_c_reactive_protein	C-Reactive Protein (mg/dL)
317	D_LAB_serum_igd	Serum IgD (mg/L)
318	D_LAB_serum_ige	Serum IgE (mg/L)
319	D_QOL_Q1	
320	D_QOL_Q2	
321	D_QOL_Q3	
322	D_QOL_Q4	
323	D_QOL_Q5	
324	D_QOL_Q6	
325	D_QOL_Q7	
326	D_QOL_Q8	
327	D_QOL_Q9	
328	D_QOL_Q10	
329	D_QOL_Q11	
330	D_QOL_Q12	
331	D_QOL_Q13	
332	D_QOL_Q14	
333	D_QOL_Q15	
334	D_QOL_Q16	
335	D_QOL_Q17	
336	D_QOL_Q18	
337	D_QOL_Q19	
338	D_QOL_Q20	
339	D_QOL_Q21	
340	D_QOL_Q22	
341	D_QOL_Q23	
342	D_QOL_Q24	
343	D_QOL_Q25	
344	D_QOL_Q26	
345	D_QOL_Q27	
346	D_QOL_Q28	
347	D_QOL_Q29	
348	D_QOL_Q30	
349	D_QOL_Q31	
350	D_QOL_Q32	
351	D_QOL_Q33	
352	D_QOL_Q34	
353	D_QOL_Q35	
354	D_QOL_Q36	
355	D_QOL_Q37	
356	D_QOL_Q38	
357	D_QOL_Q39	
358	D_QOL_Q40	
359	D_QOL_Q41	
360	D_QOL_Q42	
361	D_QOL_Q43	
362	D_QOL_Q44	
363	D_QOL_Q45	
364	D_QOL_Q46	
365	D_QOL_Q47	
366	D_QOL_Q48	
367	D_QOL_Q49	
368	D_QOL_Q50	
369	D_QOL_QLQ_MY20	Was EORTC QLQ-MY20 questionnaire completed at this visit?
370	D_QOL_QOL_DY	
371	D_QOL_QLQ_C30	Was EORTC QLQ-C30 questionnaire completed at this visit?
372	D_QOL_mPF2	Mean of Physical functioning Questions
373	D_QOL_PF2	Physical functioning
374	D_QOL_mRF2	Mean of Role functioning Questions
375	D_QOL_RF2	Role functioning
376	D_QOL_mEF	Mean of Emotional functioning Questions
377	D_QOL_EF	Emotional functioning
378	D_QOL_mCF	Mean of Cognitive functioning Questions
379	D_QOL_CF	Cognitive functioning
380	D_QOL_mSF	Mean of Social functioning Questions
381	D_QOL_SF	Social functioning
382	D_QOL_mMYFP	Mean of Future perspective Questions
383	D_QOL_MYFP	Future Perspective
384	D_QOL_mMYBI	Mean of Body image Questions
385	D_QOL_MYBI	Body Image
386	D_QOL_mQL2	Mean of QL2 Questions
387	D_QOL_QL2	Global Health Status - QOL
388	D_QOL_mFA	Mean of Fatigue Questions
389	D_QOL_FA	Fatigue
390	D_QOL_mNV	Mean of Nausea and Vomiting Questions
391	D_QOL_NV	Nausea and vomiting
392	D_QOL_mPA	Mean of Pain Questions
393	D_QOL_PA	Pain
394	D_QOL_mDY	Mean of Dyspnoea Questions
395	D_QOL_DY	Dyspnoea
396	D_QOL_mSL	Mean of Insomnia Questions
397	D_QOL_SL	Insomnia
398	D_QOL_mAP	Mean of Appetite Loss Questions
399	D_QOL_AP	Appetite Loss
400	D_QOL_mCO	Mean of Constipation Questions
401	D_QOL_CO	Constipation
402	D_QOL_mDI	Mean of Diarrhoea Questions
403	D_QOL_DI	Diarrhoea
404	D_QOL_mFI	Mean of Financial difficulties Questions
405	D_QOL_FI	Financial difficulties
406	D_QOL_mMYDS	Mean of Disease symptoms Questions
407	D_QOL_MYDS	Disease Symptoms
408	D_QOL_mMYSE	Mean of Side Effects of Treatment Questions
409	D_QOL_MYSE	Side effects of treatment
410	D_QOL_enr	Enrolled Population
411	SAMPLE_TYPE	
412	SPECIMEN_ID	
413	KEATSNFKB_INDEX	
414	KEATSPROLIF_INDEX	
415	PI_PBL_INDEX	
416	UAMS70_INDEX	
417	UAMS70_CALL	
418	PI_PBL_CALL	
419	LDH_level	LDH categorized (High/Normal/Low)
421	CMMC_VISIT_NAME	CMMC Visit Name
422	CMMC_COMMENTS	CMMC Comments
423	CMMC	
424	CMMC_REASONFORPROC	CMMC Matched Sample Reason from CRF
425	CMMC_BONE_SPECIFY2	CMMC Sample Reason Specify from CRF
426	CMMC_REASONCODE	CMMC Matched Coded Sample Reason from CRF
427	CMMC_CRHIT	CMMC CR Hit
428	CMMC_PDHIT	CMMC PD Hit
429	CMMC_HIT	CMMC CR or PD Hit
430	CMMC_RECDY	CMMC Received Day
431	enr	Enrolled Population. Ignore as it is always 1 (constant column).
